您的位置: 首页 > 2023年3月 第54卷 第3期 > 文字全文
2023年7月 第38卷 第7期11
目录

血沉对川崎病冠状动脉病变的预测价值研究

Predictive value of erythrocyte sedimentation rate for coronary artery lesions in Kawasaki disease

来源期刊: 广州医药 | 25-29 发布时间:2023-04-14 收稿时间:2025/11/13 18:36:37 阅读量:33
作者:
关键词:
儿童川崎病冠状动脉病变血沉预测价值
childrenKawasaki diseasecoronary artery lesionserythrocyte sedimentation ratepredictive value
DOI:
10.3969/j.issn.1000-8535.2023.03.005
收稿时间:
2022-07-18 
修订日期:
 
接收日期:
 
引用总数:
3  
目的 探讨血沉(ESR)对川崎病(KD)冠状动脉病变(CAL)的预测价值。方法 收集 2017 年 5 月— 2021 年 6 月收治入院的KD患儿的临床资料,分析ESR对KD患儿CAL发生的预测作用。结果 纳入272例KD患儿,70例KD患儿合并CAL,202例KD患儿无CAL。KD患儿的ESR升高。单因素分析提示CAL组的ESR低于非CAL组,差异有统计学意义(P<0.05)。ROC曲线下的面积为0.586,提示ESR可作为CAL的预测因子(P<0.05)。ESR预测川崎病冠脉病变发生的临界值为76.5 mm/h。二分类Logistic回归分析显示,ESR是KD患儿发生CAL的独立危险因素(P<0.05),当ESR<76.5 mm·h-1时,KD患儿CAL发生风险增加 (OR=2.38,95% CI: 1.25~4.53)。结论 KD急性期的ESR水平可用于预测KD患儿CAL的发生,ESR<76.5 mm·h-1时,提示KD患儿可能会出现CAL。
Objective To investigate the predictive value of erythrocyte sedimentation rate (ESR) on coronary artery lesions (CAL) in Kawasaki disease (KD). Methods Clinical data of children with KD admitted to the hospital from May 2017 to June 2021 were collected to analyze the predictive value of ESR on the occurrence of CAL in children with KD. Results Of the 272 enrolled children with KD, 70 children with CAL and 202 children without CAL. ESR was significantly higher in children with KD. Univariate analysis suggested that ESR was lower in the CAL group than in the non-CAL group, and the difference was statistically significant (P<0.05). The area under the ROC curve was 0.586, suggesting that ESR could be a predictor of CAL (P<0.05). The critical value of ESR for predicting the occurrence of CAL in KD was 76.5 mm/h. Dichotomous Logistic regression analysis showed that ESR was an independent risk factor for the development of CAL in children with KD (P<0.05), and the risk of CAL in children with KD was significantly increased when ESR was<76.5 mm/h. (OR = 2.38, 95% CI: 1.25-4.53). Conclusions ESR levels in the acute phase of KD can be used to predict the development of CAL in children with KD, and ESR <76.5 mm/h suggests that children with KD may develop CAL.
1、 CHANG L S, LIN Y J, YAN J H, et al. Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease[J].BMC Pediatr, 2020,20(1):398. CHANG L S, LIN Y J, YAN J H, et al. Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease[J].BMC Pediatr, 2020,20(1):398.
2、 ZANDSTRA J, van de GEER A, TANCK M W T, et al.Biomarkers for the discrimination of acute Kawasaki disease from infections in childhood[J].Front Pediatr, 2020(8):355. ZANDSTRA J, van de GEER A, TANCK M W T, et al.Biomarkers for the discrimination of acute Kawasaki disease from infections in childhood[J].Front Pediatr, 2020(8):355.
3、 XIU-YU S, JIA-YU H, QIANG H, et al. Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis[J].J Clin Lab Anal, 2010, 24(6): 385-388. XIU-YU S, JIA-YU H, QIANG H, et al. Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis[J].J Clin Lab Anal, 2010, 24(6): 385-388.
4、 DANESH J, COLLINS R, PETO R, et al. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease[J].Eur Heart J, 2000, 21(7): 515-520. DANESH J, COLLINS R, PETO R, et al. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease[J].Eur Heart J, 2000, 21(7): 515-520.
5、 ERIKSSEN G, LIEST?L K, BJ?RNHOLT J V, et al.Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality[J].Eur Heart J, 2000, 21(19): 1614-1620. ERIKSSEN G, LIEST?L K, BJ?RNHOLT J V, et al.Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality[J].Eur Heart J, 2000, 21(19): 1614-1620.
6、 WENG H, PENG Y, PEI Q, et al. Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm[J].Pediatr Res, 2021, 89(3): 569-573. WENG H, PENG Y, PEI Q, et al. Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm[J].Pediatr Res, 2021, 89(3): 569-573.
7、 YOSHIZAWA H, NOGAMI K, MATSUMOTO T, et al.Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays[J].Thromb Res, 2019(174):76-83. YOSHIZAWA H, NOGAMI K, MATSUMOTO T, et al.Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays[J].Thromb Res, 2019(174):76-83.
8、 TALSTAD I, HAUGEN H F.The relationship between the erythrocyte sedimentation rate (ESR) and plasma proteins in clinical materials and models[J].Scand J Clin Lab Invest, 1979, 39(6): 519-524. TALSTAD I, HAUGEN H F.The relationship between the erythrocyte sedimentation rate (ESR) and plasma proteins in clinical materials and models[J].Scand J Clin Lab Invest, 1979, 39(6): 519-524.
9、 DANIELS L M, TOSH P K, FIALA J A, et al. Extremely elevated erythrocyte sedimentation rates: Associations with patients' diagnoses, demographic characteristics, and comorbidities[J].Mayo Clin Proc, 2017, 92(11): 1636-1643. DANIELS L M, TOSH P K, FIALA J A, et al. Extremely elevated erythrocyte sedimentation rates: Associations with patients' diagnoses, demographic characteristics, and comorbidities[J].Mayo Clin Proc, 2017, 92(11): 1636-1643.
10、 LEE J J Y, LIN E, WIDDIFIELD J, et al. The long-term cardiac and noncardiac prognosis of Kawasaki disease: A systematic review[J].Pediatrics, 2022, 149(3): e2021052567. LEE J J Y, LIN E, WIDDIFIELD J, et al. The long-term cardiac and noncardiac prognosis of Kawasaki disease: A systematic review[J].Pediatrics, 2022, 149(3): e2021052567.
11、 NAGATA S. Causes of Kawasaki disease-from past to present[J].Front Pediatr, 2019(7):18. NAGATA S. Causes of Kawasaki disease-from past to present[J].Front Pediatr, 2019(7):18.
12、 MCCRINDLE B W, ROWLEY A H, NEWBURGER J W, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association[J].Circulation, 2017, 135(17): e927-e999. MCCRINDLE B W, ROWLEY A H, NEWBURGER J W, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association[J].Circulation, 2017, 135(17): e927-e999.
13、 黄国英.川崎病诊断和治疗面临的挑战[J].中华儿科杂志, 2022, 60(1):3-5. 黄国英.川崎病诊断和治疗面临的挑战[J].中华儿科杂志, 2022, 60(1):3-5.
14、 DIMA A, OPRIS D, JURCUT C, et al. Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?[J].Lupus, 2016,25(11):1173-1179. DIMA A, OPRIS D, JURCUT C, et al. Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?[J].Lupus, 2016,25(11):1173-1179.
15、 KAWAI Y, MATSUYAMA H, KORENAGA Y, et al.Preoperative erythrocyte sedimentation rate is an independent prognostic factor in Japanese patients with localized clear cell renal cell carcinoma[J].Urol Int, 2009,83(3):306-310. KAWAI Y, MATSUYAMA H, KORENAGA Y, et al.Preoperative erythrocyte sedimentation rate is an independent prognostic factor in Japanese patients with localized clear cell renal cell carcinoma[J].Urol Int, 2009,83(3):306-310.
16、 ANDRESDOTTIR M B, SIGFUSSON N, SIGVALDASON H, et al. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: The Reykjavik Study[J].Am J Epidemiol, 2003,158(9):844-851. ANDRESDOTTIR M B, SIGFUSSON N, SIGVALDASON H, et al. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: The Reykjavik Study[J].Am J Epidemiol, 2003,158(9):844-851.
17、 KURT C, ALTUNCEKI C Y A.Contribution of erythrocyte sedimentation rate to predict disease severity and outcome in COVID-19 patients[J].Can J Infect Dis Med Microbiol,2022(2022):6510952. KURT C, ALTUNCEKI C Y A.Contribution of erythrocyte sedimentation rate to predict disease severity and outcome in COVID-19 patients[J].Can J Infect Dis Med Microbiol,2022(2022):6510952.
18、 CHAUDHARY H, NAMEIRAKPAM J, KUMRAH R, et al.Biomarkers for Kawasaki disease: Clinical utility and the challenges ahead[J].Front Pediatr, 2019(7):242. CHAUDHARY H, NAMEIRAKPAM J, KUMRAH R, et al.Biomarkers for Kawasaki disease: Clinical utility and the challenges ahead[J].Front Pediatr, 2019(7):242.
19、 FUKAZAWA R, KOBAYASHI J, AYUSAWA M, et al.JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease[J].Circ J, 2020, 84(8): 1348-1407. FUKAZAWA R, KOBAYASHI J, AYUSAWA M, et al.JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease[J].Circ J, 2020, 84(8): 1348-1407.
20、 中华医学会儿科学分会心血管学组, 中华儿科杂志编辑委员会.川崎病冠状动脉病变的临床处理建议(2020年修订版)[J].中华儿科杂志, 2020, 58(9):718-724. 中华医学会儿科学分会心血管学组, 中华儿科杂志编辑委员会.川崎病冠状动脉病变的临床处理建议(2020年修订版)[J].中华儿科杂志, 2020, 58(9):718-724.
1、崔智方.不同年龄段川崎病患儿的临床特点及冠状动脉病变危险因素的比较性分析[D].昆明医科大学,2024.DOI:10.27202/d.cnki.gkmyc.2024.001308. 崔智方.不同年龄段川崎病患儿的临床特点及冠状动脉病变危险因素的比较性分析[D].昆明医科大学,2024.DOI:10.27202/d.cnki.gkmyc.2024.001308.
2、吴娴婕.Kobayashi评分及Th1/Th2细胞平衡状态对IVIG无反应性川崎病患儿并发冠状动脉病变的预测价值[D].海南医科大学,2025.DOI:10.27952/d.cnki.ghnyx.2025.000243. 吴娴婕.Kobayashi评分及Th1/Th2细胞平衡状态对IVIG无反应性川崎病患儿并发冠状动脉病变的预测价值[D].海南医科大学,2025.DOI:10.27952/d.cnki.ghnyx.2025.000243.
3、郑丽平,朱利敏.1例IVIg无应答型川崎病患儿的中西医结合护理[J].当代护士(下旬刊),2025,32(04):63-66.DOI:10.19793/j.cnki.1006-6411.2025.12.014. 郑丽平,朱利敏.1例IVIg无应答型川崎病患儿的中西医结合护理[J].当代护士(下旬刊),2025,32(04):63-66.DOI:10.19793/j.cnki.1006-6411.2025.12.014.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录